Cargando…
Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances
Autores principales: | Kassi, Eva, Kyrou, Ioannis, Randeva, Harpal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253952/ https://www.ncbi.nlm.nih.gov/pubmed/37298686 http://dx.doi.org/10.3390/ijms24119737 |
Ejemplares similares
-
Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2022) -
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
por: Androutsakos, Theodoros, et al.
Publicado: (2022) -
Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2022) -
COVID-19 and diabetes: No time to drag our feet during an untimely pandemic()
por: Kyrou, Ioannis, et al.
Publicado: (2020) -
Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction
por: Barber, Thomas M., et al.
Publicado: (2021)